- DocumentoAn Introduction to Kinases and Kinase Inhibitorsenviado porBiotech Investors' Database
- DocumentoLa Transformation d'Oncodesign ... à Paris-Saclayenviado porBiotech Investors' Database
- DocumentoOncodesign in Paris-Saclayenviado porBiotech Investors' Database
- DocumentoThe Big Picture For Genfit_NASH+diabetes+CVDenviado porBiotech Investors' Database
- DocumentoNo Doubt Genfit's Elafibranor cures Nashenviado porBiotech Investors' Database
- DocumentoNew Genfit Data Challenge Placebo-Positive and Elafibranor-Negative Biopsy Interpretationsenviado porBiotech Investors' Database
- DocumentoL'Action Du GFT505 Sur Les Récepteurs Nucléaires PPARenviado porBiotech Investors' Database
- DocumentoCellectis Demonstrates Potential of Allogenic CAR-T Technologyenviado porBiotech Investors' Database
- DocumentoThe Paradox of Obeticholic Acid for the Treatment of NASHenviado porBiotech Investors' Database
- DocumentoGFT505, Genfit's PPAR Agonist for the Treatment of NASHenviado porBiotech Investors' Database